IPN Ipsen SA

IPSEN : Déclaration des transactions sur actions propres réalisées du 12/06/2017 au 16/06/2017

PARIS--(BUSINESS WIRE)--

Regulatory News:

Présentation agrégée par jour et par marché

                         
Nom de l'émetteur   Code identifiant de l'émetteur (code LEI)   Jour de la transaction   Code identifiant de l'instrument financier   Volume total journalier (en nombre de titres)   Prix pondéré moyen journalier d'acquisition   Code identifiant marché
IPSEN   549300M6SGDPB4Z94P11   2017.06.12   FR0010259150   3450   116.75   XPAR
IPSEN   549300M6SGDPB4Z94P11   2017.06.12   FR0010259150   150   117.80   TRQX
IPSEN 549300M6SGDPB4Z94P11 2017.06.13 FR0010259151 1575 116.38 XPAR
IPSEN   549300M6SGDPB4Z94P11   2017.06.13   FR0010259152   25   116.25   CHIX
IPSEN   549300M6SGDPB4Z94P11   2017.06.14   FR0010259153   1600   116.14   XPAR
IPSEN 549300M6SGDPB4Z94P11 2017.06.15 FR0010259154 1550 116.25 XPAR
IPSEN 549300M6SGDPB4Z94P11 2017.06.15 FR0010259155 25 115.60 TRQX
IPSEN   549300M6SGDPB4Z94P11   2017.06.15   FR0010259156   25   115.85   CHIX
IPSEN   549300M6SGDPB4Z94P11   2017.06.16   FR0010259157   239   118.04   XPAR

L'information détaillée transaction par transaction des opérations réalisées ainsi que les objectifs de rachat sont disponibles sur le site internet de la société à l'adresse suivante: http://www.ipsen.com/fr/investisseurs/information-reglementee/

FR
21/06/2017

Underlying

IPNIpsen SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ipsen SA

CON CONTINENTAL AKTIENGESELLSCHAFT
INFINEON INFINEON TECHNOLOGIES AG
LOGN LOGITECH INTERNATIONAL S.A.
FP TOTAL SE
GET GETLINK SE
IPN IPSEN SA
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
DB1 DEUTSCHE BOERSE AG
BN DANONE SA
ORA ORANGE SA
EN BOUYGUES SA
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
ENI ENI S.P.A.
COTN COMET HOLDING AG
CICN CICOREL HOLDING S.A.
ORSTED ORSTED
VOW3 VOLKSWAGEN AG PREF
REP REPSOL SA
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
NOD NORDIC SEMICONDUCTOR ASA
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
BP. BP P.L.C.
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
CCEP COCA-COLA EUROPEAN PARTNERS PLC
SIK SIKA AG
JEN JENOPTIK AG
EQT EQT AB
SHEL SHELL PLC
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
IFCN INFICON HOLDING AG
14h / 45m 14h / 45m 1 EN
CON CONTINENTAL AKTIENGESELLSCHAFT
INFINEON INFINEON TECHNOLOGIES AG
LOGN LOGITECH INTERNATIONAL S.A.
FP TOTAL SE
GET GETLINK SE
IPN IPSEN SA
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
DB1 DEUTSCHE BOERSE AG
BN DANONE SA
ORA ORANGE SA
EN BOUYGUES SA
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
ENI ENI S.P.A.
COTN COMET HOLDING AG
CICN CICOREL HOLDING S.A.
ORSTED ORSTED
VOW3 VOLKSWAGEN AG PREF
REP REPSOL SA
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
NOD NORDIC SEMICONDUCTOR ASA
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
BP. BP P.L.C.
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
CCEP COCA-COLA EUROPEAN PARTNERS PLC
SIK SIKA AG
JEN JENOPTIK AG
EQT EQT AB
SHEL SHELL PLC
ARM ARM HOLDINGS PLC
AMS AMS-OSRAM AG
IFCN INFICON HOLDING AG
15h / 9m 15h / 9m 1 FR
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
16h / 9m 16h / 9m 1 EN
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
16h / 39m 16h / 39m 1 FR
 PRESS RELEASE
Free
IPN IPSEN SA

Arbitration tribunal upholds Ipsen’s termination of R&D agreement with...

Arbitration tribunal upholds Ipsen’s termination of R&D agreement with Galderma PARIS, FRANCE, 21 January 2026 – Ipsen (Euronext: IPN; ADR: IPSEY) announced that the Arbitral Tribunal of the International Chamber of Commerce (ICC) has issued a final decision in favor of Ipsen, dismissing the claim initiated by Galderma in the arbitration proceedings related to Ipsen’s termination of the R&D agreement. The ICC Tribunal’s decision confirms Ipsen’s full rights to its clinical stage toxin programs in the aesthetic field. “This decisive ICC ruling supports Ipsen’s leadership position in neuros...

January 21, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch